T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$4.36T
| $11B | 2.44% |
352,309,320
-20,364,740
| -5% | -$626M |
|
2
Amazon
AMZN
$2.92T
| $10.8B | 2.4% |
420,632,300
+4,618,120
| +1% | +$117M |
|
|
3
Microsoft
MSFT
$3.45T
| $7.61B | 1.69% |
171,946,937
+34,946,210
| +26% | +$1.57B |
|
4
Danaher
DHR
$137B
| $7.04B | 1.57% |
122,928,810
-4,602,349
| -4% | -$272M |
|
5
Booking.com
BKNG
$149B
| $6.72B | 1.5% |
135,874,400
+813,675
| +0.6% | +$40.4M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $6.12B | 1.36% |
22,513,722
+846,972
| +4% | +$260M |
|
7
Visa
V
$684B
| $5.7B | 1.27% |
81,881,728
-8,846,382
| -10% | -$631M |
|
8
Meta Platforms (Facebook)
META
$1.42T
| $5.49B | 1.22% |
61,069,269
+818,667
| +1% | +$75.1M |
|
9
Boeing
BA
$171B
| $5.4B | 1.2% |
41,218,993
+1,448,326
| +4% | +$201M |
|
10
Apple
AAPL
$4.54T
| $5.15B | 1.15% |
186,849,216
-4,992,036
| -3% | -$146M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.37B | 0.97% |
27,941,721
+1,739,186
| +7% | +$317M |
|
12
UnitedHealth
UNH
$376B
| $4.21B | 0.94% |
36,284,058
+2,508,306
| +7% | +$300M |
|
13
GE Aerospace
GE
$374B
| $4.12B | 0.92% |
34,099,139
+470,155
| +1% | +$57.6M |
|
14
Gilead Sciences
GILD
$162B
| $3.83B | 0.85% |
39,009,926
-4,303,477
| -10% | -$478M |
|
15
JPMorgan Chase
JPM
$935B
| $3.69B | 0.82% |
60,478,588
-747,481
| -1% | -$49M |
|
16
Mastercard
MA
$506B
| $3.67B | 0.82% |
40,705,240
+4,022,909
| +11% | +$378M |
|
17
Bausch Health
BHC
$2.57B
| $3.58B | 0.8% |
20,046,911
-416,721
| -2% | -$97.2M |
|
|
MRSH
18
Marsh
MRSH
$90.5B
| $3.52B | 0.78% |
67,341,264
+6,779,287
| +11% | +$379M |
|
19
Morgan Stanley
MS
$331B
| $3.48B | 0.77% |
110,547,878
+5,460,532
| +5% | +$199M |
|
20
American Airlines Group
AAL
$10.1B
| $3.35B | 0.75% |
86,371,216
+8,445,719
| +11% | +$347M |
|
21
Pfizer
PFE
$143B
| $3.29B | 0.73% |
110,341,561
+3,348,271
| +3% | +$107M |
|
|
22
Elevance Health
ELV
$81.5B
| $3.28B | 0.73% |
23,419,662
+7,748,867
| +49% | +$1.16B |
|
|
FISV
23
Fiserv Inc
FISV
$28.8B
| $3.2B | 0.71% |
73,917,456
+2,765,148
| +4% | +$120M |
|
|
24
McKesson
MCK
$100B
| $3.16B | 0.7% |
17,074,508
-5,650,447
| -25% | -$1.2B |
|
|
CELG
25
DELISTED
Celgene Corp
CELG
| $3.05B | 0.68% |
28,171,466
+528,991
| +2% | +$65.6M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.